Molecular Modeling of Prion Transmission to Humans

Using different prion strains, such as the variant Creutzfeldt-Jakob disease agent and the atypical bovine spongiform encephalopathy agents, and using transgenic mice expressing human or bovine prion protein, we assessed the reliability of protein misfolding cyclic amplification (PMCA) to model int...

Full description

Bibliographic Details
Main Authors: Etienne Levavasseur, Nicolas Privat, Juan-Carlos Espinosa Martin, Steve Simoneau, Thierry Baron, Benoit Flan, Juan-Maria Torres, Stéphane Haïk
Format: Article
Language:English
Published: MDPI AG 2014-10-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/6/10/3766
id doaj-9c58f6951438455d8d0eacd3b54c1b09
record_format Article
spelling doaj-9c58f6951438455d8d0eacd3b54c1b092020-11-24T23:13:51ZengMDPI AGViruses1999-49152014-10-016103766377710.3390/v6103766v6103766Molecular Modeling of Prion Transmission to HumansEtienne Levavasseur0Nicolas Privat1Juan-Carlos Espinosa Martin2Steve Simoneau3Thierry Baron4Benoit Flan5Juan-Maria Torres6Stéphane Haïk7Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ. Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, 75013 Paris, FranceInserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ. Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, 75013 Paris, FranceCentro de Investigacion en Sanidad Animal, Carretera de Algete a El Casar, 28130 Madrid, SpainLFB Biomédicaments, 91958 Les Ulis, FranceAgence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Unité Maladies neurodégénératives, 69394 Lyon, FranceLFB Biomédicaments, 91958 Les Ulis, FranceCentro de Investigacion en Sanidad Animal, Carretera de Algete a El Casar, 28130 Madrid, SpainInserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ. Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, 75013 Paris, FranceUsing different prion strains, such as the variant Creutzfeldt-Jakob disease agent and the atypical bovine spongiform encephalopathy agents, and using transgenic mice expressing human or bovine prion protein, we assessed the reliability of protein misfolding cyclic amplification (PMCA) to model interspecies and genetic barriers to prion transmission. We compared our PMCA results with in vivo transmission data characterized by attack rates, i.e., the percentage of inoculated mice that developed the disease. Using 19 seed/substrate combinations, we observed that a significant PMCA amplification was only obtained when the mouse line used as substrate is susceptible to the corresponding strain. Our results suggest that PMCA provides a useful tool to study genetic barriers to transmission and to study the zoonotic potential of emerging prion strains.http://www.mdpi.com/1999-4915/6/10/3766PrionProtein misfolding cyclic amplificationmolecular modelinterspecies barrier
collection DOAJ
language English
format Article
sources DOAJ
author Etienne Levavasseur
Nicolas Privat
Juan-Carlos Espinosa Martin
Steve Simoneau
Thierry Baron
Benoit Flan
Juan-Maria Torres
Stéphane Haïk
spellingShingle Etienne Levavasseur
Nicolas Privat
Juan-Carlos Espinosa Martin
Steve Simoneau
Thierry Baron
Benoit Flan
Juan-Maria Torres
Stéphane Haïk
Molecular Modeling of Prion Transmission to Humans
Viruses
Prion
Protein misfolding cyclic amplification
molecular model
interspecies barrier
author_facet Etienne Levavasseur
Nicolas Privat
Juan-Carlos Espinosa Martin
Steve Simoneau
Thierry Baron
Benoit Flan
Juan-Maria Torres
Stéphane Haïk
author_sort Etienne Levavasseur
title Molecular Modeling of Prion Transmission to Humans
title_short Molecular Modeling of Prion Transmission to Humans
title_full Molecular Modeling of Prion Transmission to Humans
title_fullStr Molecular Modeling of Prion Transmission to Humans
title_full_unstemmed Molecular Modeling of Prion Transmission to Humans
title_sort molecular modeling of prion transmission to humans
publisher MDPI AG
series Viruses
issn 1999-4915
publishDate 2014-10-01
description Using different prion strains, such as the variant Creutzfeldt-Jakob disease agent and the atypical bovine spongiform encephalopathy agents, and using transgenic mice expressing human or bovine prion protein, we assessed the reliability of protein misfolding cyclic amplification (PMCA) to model interspecies and genetic barriers to prion transmission. We compared our PMCA results with in vivo transmission data characterized by attack rates, i.e., the percentage of inoculated mice that developed the disease. Using 19 seed/substrate combinations, we observed that a significant PMCA amplification was only obtained when the mouse line used as substrate is susceptible to the corresponding strain. Our results suggest that PMCA provides a useful tool to study genetic barriers to transmission and to study the zoonotic potential of emerging prion strains.
topic Prion
Protein misfolding cyclic amplification
molecular model
interspecies barrier
url http://www.mdpi.com/1999-4915/6/10/3766
work_keys_str_mv AT etiennelevavasseur molecularmodelingofpriontransmissiontohumans
AT nicolasprivat molecularmodelingofpriontransmissiontohumans
AT juancarlosespinosamartin molecularmodelingofpriontransmissiontohumans
AT stevesimoneau molecularmodelingofpriontransmissiontohumans
AT thierrybaron molecularmodelingofpriontransmissiontohumans
AT benoitflan molecularmodelingofpriontransmissiontohumans
AT juanmariatorres molecularmodelingofpriontransmissiontohumans
AT stephanehaik molecularmodelingofpriontransmissiontohumans
_version_ 1725596431693119488